01 66ABBVIE
Patent Expiration Date : 2029-03-24
US Patent Number : 8039009
Drug Substance Claim :
Drug Product Claim :
Application Number : 22525
Patent Use Code : U-539
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-03-24
Patent Expiration Date : 2029-03-24
US Patent Number : 8039009
Drug Substance Claim :
Drug Product Claim :
Application Number : 22525
Patent Use Code : U-539
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-03-24
Patent Expiration Date : 2025-11-22
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8173708
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested : Y
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2025-11-22
Patent Expiration Date : 2025-11-22
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8173708
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested : Y
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2025-11-22
Patent Expiration Date : 2025-11-22
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8362085
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested : Y
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2025-11-22
Patent Expiration Date : 2029-03-24
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8039009
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested :
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2029-03-24
Patent Expiration Date : 2029-12-05
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8058291
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested :
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2029-12-05
Patent Expiration Date : 2025-11-22
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8338486
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested :
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2025-11-22
Patent Expiration Date : 2029-12-05
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8058291
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested :
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2029-12-05
Patent Expiration Date : 2025-11-22
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8283379
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested : Y
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2025-11-22